NO20091428L - Forbindelser og metoder for 18F-merkede midler - Google Patents
Forbindelser og metoder for 18F-merkede midlerInfo
- Publication number
- NO20091428L NO20091428L NO20091428A NO20091428A NO20091428L NO 20091428 L NO20091428 L NO 20091428L NO 20091428 A NO20091428 A NO 20091428A NO 20091428 A NO20091428 A NO 20091428A NO 20091428 L NO20091428 L NO 20091428L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- methods
- labeled agents
- labeled
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57545—Neuropeptide Y
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06090166A EP1897885A1 (fr) | 2006-09-08 | 2006-09-08 | Composés marqués au fluor et méthode pour la production |
EP07090079A EP1985624A3 (fr) | 2007-04-23 | 2007-04-23 | Procédé simple de radiofluorination de composés actifs biologiquement ou de biomolécules |
PCT/EP2007/008042 WO2008028688A2 (fr) | 2006-09-08 | 2007-09-07 | Composés et procédés associés à des agents étiquetés 18f |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20091428L true NO20091428L (no) | 2009-06-03 |
Family
ID=39031005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091428A NO20091428L (no) | 2006-09-08 | 2009-04-07 | Forbindelser og metoder for 18F-merkede midler |
Country Status (20)
Country | Link |
---|---|
US (1) | US8557776B2 (fr) |
EP (5) | EP2289564A3 (fr) |
JP (2) | JP5603074B2 (fr) |
KR (1) | KR20090058553A (fr) |
AR (1) | AR062726A1 (fr) |
AU (1) | AU2007294124A1 (fr) |
BR (1) | BRPI0716554A2 (fr) |
CA (2) | CA2858907A1 (fr) |
CL (1) | CL2007002620A1 (fr) |
CO (1) | CO6150196A2 (fr) |
CR (1) | CR10654A (fr) |
IL (4) | IL197363A0 (fr) |
MA (1) | MA30780B1 (fr) |
MX (1) | MX2009002492A (fr) |
NO (1) | NO20091428L (fr) |
PE (1) | PE20080850A1 (fr) |
RU (1) | RU2009112716A (fr) |
TN (1) | TN2009000063A1 (fr) |
TW (1) | TW200829277A (fr) |
WO (1) | WO2008028688A2 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008028688A2 (fr) | 2006-09-08 | 2008-03-13 | Bayer Schering Pharma Aktiengesellschaft | Composés et procédés associés à des agents étiquetés 18f |
EA200901142A1 (ru) * | 2007-03-01 | 2010-04-30 | Байер Шеринг Фарма Акциенгезельшафт | 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники |
GB201013808D0 (en) | 2010-08-18 | 2010-09-29 | Ge Healthcare Ltd | Peptide radiotracer compositions |
WO2012094334A1 (fr) * | 2011-01-04 | 2012-07-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Marquage au 18f en une seule étape de substrats biologiques et utilisations desdits substrats biologiques marqués au 18f |
CA2838198A1 (fr) * | 2011-06-09 | 2012-12-13 | Ge Healthcare Limited | Dispositif et procede de distillation |
PL2970345T3 (pl) * | 2013-03-15 | 2019-12-31 | Cancer Targeted Technology Llc | Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA |
GB201314936D0 (en) | 2013-08-21 | 2013-10-02 | Ge Healthcare Ltd | Radiolabelling method |
GB201322456D0 (en) | 2013-12-18 | 2014-02-05 | Ge Healthcare Ltd | Radiotracer compositions and methods |
WO2018152339A1 (fr) * | 2017-02-17 | 2018-08-23 | Yale University | Agents pharmaceutiques radiomarqués et procédés d'utilisation de ceux-ci |
SG11202000167SA (en) | 2017-07-11 | 2020-02-27 | Synthorx Inc | Incorporation of unnatural nucleotides and methods thereof |
MA49770A (fr) | 2017-08-03 | 2021-05-26 | Synthorx Inc | Conjugués de cytokine destinés au traitement de maladies prolifératives et infectieuses |
JP2021522196A (ja) * | 2018-04-20 | 2021-08-30 | ザ ジェネラル ホスピタル コーポレイション | 血液脳関門を越えて送達するためのアセチル化プロドラッグ |
EP3923974A4 (fr) | 2019-02-06 | 2023-02-08 | Synthorx, Inc. | Conjugués d'il-2 et méthodes d'utilisation de ceux-ci |
WO2022246118A2 (fr) * | 2021-05-20 | 2022-11-24 | The Regents Of The University Of California | Traceurs d'imagerie pet |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723578A (en) * | 1987-09-24 | 1998-03-03 | The Administrators Of Tulane Educational Fund | Peptide analogs of bombesin |
US5084555A (en) | 1989-08-21 | 1992-01-28 | The Administrators Of The Tulane Educational Fund | An octapeptide bombesin analog |
JP2795449B2 (ja) * | 1987-09-24 | 1998-09-10 | ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド | 治療用ペプチド |
DE68928667T2 (de) * | 1988-10-14 | 1998-10-01 | Univ Tulane | Peptide als arzneimittel |
US5342755A (en) * | 1989-06-02 | 1994-08-30 | Georgetown University | Method for the detection of anti-streptokinase antibodies |
US6232071B1 (en) | 1990-06-11 | 2001-05-15 | Gilead Sciences, Inc. | Tenascin-C nucleic acid ligands |
US5244883A (en) * | 1990-11-29 | 1993-09-14 | The Administrators Of The Tulane Educational Fund | Nonapeptide bombesin antagonists |
TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
PL341762A1 (en) | 1997-12-24 | 2001-05-07 | Vertex Pharma | Precursors of aspartil protease inhibitors |
WO1999033795A1 (fr) | 1997-12-24 | 1999-07-08 | Vertex Pharmaceuticals Incorporated | Promedicaments de la classe des inhibiteurs d'aspartyle protease |
AU2010299A (en) | 1997-12-24 | 1999-07-19 | Vertex Pharmaceuticals Incorporated | Prodrugs os aspartyl protease inhibitors |
US6639076B1 (en) * | 1998-08-18 | 2003-10-28 | Eli Lilly And Company | Growth hormone secretagogues |
DE60022508T2 (de) | 1999-06-14 | 2006-06-08 | Eli Lilly And Co., Indianapolis | Inhibitoren von serin proteasen |
AU2002228725A1 (en) | 2000-11-30 | 2002-06-11 | Advanced Research And Technology Institute, Inc. | Nucleophilic approach for preparing radiolabeled imaging agents and associated compounds |
GB0115927D0 (en) * | 2001-06-29 | 2001-08-22 | Nycomed Amersham Plc | Solid-phase nucleophilic fluorination |
GB0206750D0 (en) | 2002-03-22 | 2002-05-01 | Amersham Plc | Radiofluorination methods |
DE60306636T2 (de) * | 2002-04-09 | 2007-07-05 | Eli Lilly And Co., Indianapolis | Wachstumhormonsekretionsförderer |
ES2299749T3 (es) * | 2002-08-09 | 2008-06-01 | Astellas Pharma Europe B.V. | Compuestos que se unen a p-selectina. |
US20080063599A1 (en) | 2002-11-18 | 2008-03-13 | Jorge Setoain Quinquer | Compounds Which Can Be Used To Diagnose And Monitor Diseases Associated With The Formation Of Amyloid Protein Fibrils |
WO2004073650A2 (fr) * | 2003-02-20 | 2004-09-02 | University Of South Florida | Inhibiteurs peptidomimetiques de l'activite de stat et utilisations de ceux-ci |
GB0305704D0 (en) | 2003-03-13 | 2003-04-16 | Amersham Plc | Radiofluorination methods |
WO2006083424A2 (fr) | 2004-12-28 | 2006-08-10 | The Trustees Of Columbia University In The City Of New York | Composes radiomarques et utilisations de ceux-ci |
CN101583352A (zh) | 2005-07-29 | 2009-11-18 | 拜尔健康护理有限责任公司 | 治疗肥胖症的联苯氨基酸衍生物的制备和用途 |
US20080029548A1 (en) | 2006-05-05 | 2008-02-07 | Ann De Wree | Fabric treatment dispensing package |
WO2008028688A2 (fr) | 2006-09-08 | 2008-03-13 | Bayer Schering Pharma Aktiengesellschaft | Composés et procédés associés à des agents étiquetés 18f |
-
2007
- 2007-09-07 WO PCT/EP2007/008042 patent/WO2008028688A2/fr active Application Filing
- 2007-09-07 RU RU2009112716/15A patent/RU2009112716A/ru not_active Application Discontinuation
- 2007-09-07 CA CA2858907A patent/CA2858907A1/fr not_active Abandoned
- 2007-09-07 EP EP20100183074 patent/EP2289564A3/fr not_active Withdrawn
- 2007-09-07 EP EP10183062.8A patent/EP2279759A3/fr not_active Withdrawn
- 2007-09-07 CA CA002662449A patent/CA2662449A1/fr not_active Abandoned
- 2007-09-07 EP EP16153790.7A patent/EP3056509A1/fr not_active Ceased
- 2007-09-07 KR KR1020097007141A patent/KR20090058553A/ko not_active Application Discontinuation
- 2007-09-07 AU AU2007294124A patent/AU2007294124A1/en not_active Abandoned
- 2007-09-07 US US11/851,910 patent/US8557776B2/en active Active
- 2007-09-07 MX MX2009002492A patent/MX2009002492A/es not_active Application Discontinuation
- 2007-09-07 BR BRPI0716554-4A2A patent/BRPI0716554A2/pt not_active IP Right Cessation
- 2007-09-07 EP EP07802326.4A patent/EP2063918B1/fr active Active
- 2007-09-07 JP JP2009527069A patent/JP5603074B2/ja active Active
- 2007-09-07 EP EP11193716.5A patent/EP2455105B1/fr active Active
- 2007-09-10 TW TW096133780A patent/TW200829277A/zh unknown
- 2007-09-10 PE PE2007001212A patent/PE20080850A1/es not_active Application Discontinuation
- 2007-09-10 AR ARP070103993A patent/AR062726A1/es unknown
- 2007-09-10 CL CL200702620A patent/CL2007002620A1/es unknown
-
2009
- 2009-02-27 TN TN2009000063A patent/TN2009000063A1/fr unknown
- 2009-03-03 IL IL197363A patent/IL197363A0/en unknown
- 2009-03-05 CR CR10654A patent/CR10654A/es not_active Application Discontinuation
- 2009-03-06 CO CO09023386A patent/CO6150196A2/es unknown
- 2009-04-06 MA MA31764A patent/MA30780B1/fr unknown
- 2009-04-07 NO NO20091428A patent/NO20091428L/no not_active Application Discontinuation
-
2011
- 2011-02-03 IL IL211033A patent/IL211033A0/en unknown
- 2011-03-03 IL IL211527A patent/IL211527A0/en unknown
- 2011-03-03 IL IL211526A patent/IL211526A0/en unknown
-
2013
- 2013-08-16 JP JP2013169253A patent/JP5722966B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20091428L (no) | Forbindelser og metoder for 18F-merkede midler | |
NO20083598L (no) | Karbosykliske og heterosykliske arylsulfoner som inhibitorer av gamma-sekretase | |
EA201100875A1 (ru) | Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов | |
EA200901609A1 (ru) | Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов | |
CL2008002703A1 (es) | Compuestos derivados de 1,4-dihidro-2h-piridazin-3-ona; composicion herbicida que comprende a dichos compuestos; metodo de control de malezas; uso de dichos compuestos para el control de malezas; y compuestos intermediarios. | |
ECSP10010722A (es) | Compuestos orgánicos | |
AR082519A1 (es) | Fenilamidinas que tienen alta actividad fungicida, y su utilizacion | |
NO20071880L (no) | Diagnostic Compounds | |
NO20074093L (no) | Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav | |
PE20120250A1 (es) | Composicion farmaceutica que comprende derivados de glucopiranosil difenilmetano, forma farmaceutica de la misma, procedimiento para su preparacion | |
EA201101148A1 (ru) | Новые гербициды | |
EA201101099A1 (ru) | Гербициды, полученные из циклопентадиона | |
EA201101060A1 (ru) | Новые гербициды | |
UA106880C2 (uk) | Нові гербіциди | |
NO20091735L (no) | Radiofluorering | |
EA201101146A1 (ru) | Новые гербициды | |
CL2008003472A1 (es) | Compuestos derivados de 5-[3,3,3-trifluoro-2-hidroxi-1-arilpropil)amino]-1h-quinolin-2-ona, proceso para la preparacion de los mismos, compuestos intermediarios, composicion farmaceutica que comprende dicho compuesto; combinacion farmaceutica, y sus usos en el tratamiento de enfermedades inflamatorias. | |
EA200901142A1 (ru) | 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники | |
WO2009127718A3 (fr) | Nouveaux microbiocides | |
NO20074897L (no) | Radioaktive halogenmerkede fenyloksyanilinderivater | |
WO2009003672A3 (fr) | Nouveaux microbiocides | |
EA201101097A1 (ru) | Новые микробиоциды | |
RU2009138470A (ru) | Композиция для наружного применения на коже | |
NO20092813L (no) | Radiomerking via fluorinering av aziridiner | |
ATE514679T1 (de) | Biarylcarboxyarylamide als modulatoren des vanilloid-1-rezeptors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |